Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing
Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750